Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Phexxi gel to prevent pregnancy

May 25, 2020

FDA approves Lynparza for HRR gene-mutated castration-resistant prostate cancer

May 20, 2020

FDA approves Qinlock for fourth-line treatment of advanced GIST

May 18, 2020

FDA grants accelerated approval to Rubraca for BRCA-mutated metastatic CRPC

May 18, 2020

Opdivo + Yervoy approved in U.S. for first-line metastatic NSCLC with PD-L1 expression >= 1%

May 18, 2020

FDA approves Pomalyst for AIDS-related and HIV-negative Kaposi sarcoma

May 18, 2020

Lyfaquin approved in India for hypovolemic shock

May 15, 2020

FDA approves Retevmo for advanced RET-driven lung and thyroid cancers

May 11, 2020

Remdesivir receives Japanese approval for severe COVID-19

May 8, 2020

FDA approves Tabrecta for metastatic NSCLC with METex14

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...